Medicamen Biotech Limited has informed the Exchange regarding 'Declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2025'.